Invited Speakers: Richard Heyman, Ligand
Carl Thummel, University of Utah
Dana Fowlkes, Novalon
Vincent Giguere, Royal Victoria Hospital
Barry Forman, City of Hope
Martin Privalsky, U. of California, Davis
Sietse Mosselman, N.V. Organon
Bernd Stein, Signal
Thomas Brown, Pfizer
Tauseef Butt, LifeSensors
Na Yang, Eli Lilly
Heidi Camp, Parke-Davis
Andrea Fanjul, Maxia
Randall Bolger, PanVEra
Bethany Janowski, UT Southwestern Medical
George Farmer, Memorial Sloan-Kettering
Bryan Lemon, U. of California, Berkeley
Sara Peleg, MD Anderson
Jeffery Nordstrom, GeneMedicine
Program:
The benefits of Nuclear Hormone Receptor research to potential therapeutic applications for cancer, osteoporosis, diabetes, and other diseases are extremely far-reaching. The field encompasses a wide range of research opportunities. The technology in co-activators and co-repressors, screens and assays, Selective Estrogen Receptor Modulators (SERMs), and orphan receptors is constantly advancing. Therefore, the need to position your organization at the forefront of these discoveries to stay competitive in marketplace is imperative.
The Institute for International Research is proud to present the “Nuclear Hormone Receptors” conference! This timely program offers a unique opportunity to hear from industry, academic, and clinical researchers all in one forum! The presentations provide each delegate with applicable, well-rounded information that does not come from just one perspective.
Find Out What the Industry Leaders Are Doing
Benefit by getting the most recent advances on the structure and function of nuclear hormone receptors, orphans, co-activators and co-repressor, screens and assays for receptor targets, and SERM’s by the leading-edge companies and research institutions. Hear directly from our faculty of internationally recognized industry and academic experts to find out how to:
Identify the next generation of SERMs for the treatment of osteoporosis and cancer
Profit from a physiologic demonstration that LXR alpha is an indispensible regulator of dietary cholesterol homeostasis
Assess how novel retinoid-related molecules can be developed for the treatment of cancer diabetes
Implement the latest information about the co-activator ARC/DRIP complex
Incorporate research in Orphan Receptors from Gene to Function to Drug Discovery
Utilize the latest developments in flourescence polarization for high-throughput screening for estrogen receptor alpha and beta
SIGN UP FOR THIS PRE-CONFERENCE INTERACTIVE SYMPOSIUM!
“ESTROGEN RECEPTORS” is a tutorial you won’t want to miss. Learn the most up to date techniques and technologies used to develop therapeutic applications for cancer and metabolic disease. Receive a well-rounded perspective from leaders in industry, academia, and clinical research. This forum promotes an atmosphere designed to help you interact with the faculty as they discuss their latest results and data.
Registration :
As a registered delegate, you receive a complete set of program documentation submitted by the speakers -- a valuable tool for future reference. Register today! Space is limited. Take advantage of our special group discount -- send 3, the 4th attends at No Charge! Call for details. Or, if you prefer, phone us at (888) 670-8200 US ; (941) 951-7885 Int’l or fax (941) 365-2507. We look forward to greeting you in San Francisco!
Deadline for Abstracts: Poster Submission due by May 24, 1999
Email for Requests and Registration: register@iir-ny.com